nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—UGT2B7—Carbamazepine—epilepsy syndrome	0.174	0.462	CbGbCtD
Epirubicin—UGT2B7—Valproic Acid—epilepsy syndrome	0.104	0.276	CbGbCtD
Epirubicin—ABCC1—Phenobarbital—epilepsy syndrome	0.099	0.262	CbGbCtD
Epirubicin—CHD1—hindbrain—epilepsy syndrome	0.00645	0.0881	CbGeAlD
Epirubicin—CHD1—brainstem—epilepsy syndrome	0.0037	0.0505	CbGeAlD
Epirubicin—CHD1—telencephalon—epilepsy syndrome	0.00328	0.0448	CbGeAlD
Epirubicin—AURKA—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.00321	0.581	CbGdCrCtD
Epirubicin—CHD1—medulla oblongata—epilepsy syndrome	0.00258	0.0352	CbGeAlD
Epirubicin—DHCR7—forebrain—epilepsy syndrome	0.00241	0.0328	CbGeAlD
Epirubicin—CHD1—midbrain—epilepsy syndrome	0.00236	0.0322	CbGeAlD
Epirubicin—CHD1—spinal cord—epilepsy syndrome	0.0023	0.0314	CbGeAlD
Epirubicin—DHCR7—telencephalon—epilepsy syndrome	0.00221	0.0302	CbGeAlD
Epirubicin—YWHAG—forebrain—epilepsy syndrome	0.00221	0.0301	CbGeAlD
Epirubicin—CHD1—head—epilepsy syndrome	0.00204	0.0279	CbGeAlD
Epirubicin—YWHAG—telencephalon—epilepsy syndrome	0.00203	0.0277	CbGeAlD
Epirubicin—CHD1—nervous system—epilepsy syndrome	0.00194	0.0264	CbGeAlD
Epirubicin—CHD1—central nervous system—epilepsy syndrome	0.00187	0.0255	CbGeAlD
Epirubicin—CHD1—cerebellum—epilepsy syndrome	0.00182	0.0249	CbGeAlD
Epirubicin—DHCR7—medulla oblongata—epilepsy syndrome	0.00174	0.0237	CbGeAlD
Epirubicin—AURKA—head—epilepsy syndrome	0.00165	0.0225	CbGeAlD
Epirubicin—YWHAG—medulla oblongata—epilepsy syndrome	0.0016	0.0218	CbGeAlD
Epirubicin—DHCR7—midbrain—epilepsy syndrome	0.00159	0.0217	CbGeAlD
Epirubicin—AURKA—nervous system—epilepsy syndrome	0.00156	0.0213	CbGeAlD
Epirubicin—DHCR7—spinal cord—epilepsy syndrome	0.00155	0.0212	CbGeAlD
Epirubicin—AURKA—central nervous system—epilepsy syndrome	0.0015	0.0205	CbGeAlD
Epirubicin—CHD1—brain—epilepsy syndrome	0.00148	0.0202	CbGeAlD
Epirubicin—YWHAG—midbrain—epilepsy syndrome	0.00146	0.0199	CbGeAlD
Epirubicin—Doxorubicin—NOS1—epilepsy syndrome	0.00145	0.259	CrCbGaD
Epirubicin—YWHAG—spinal cord—epilepsy syndrome	0.00142	0.0194	CbGeAlD
Epirubicin—DHCR7—head—epilepsy syndrome	0.00138	0.0188	CbGeAlD
Epirubicin—DHCR7—nervous system—epilepsy syndrome	0.00131	0.0178	CbGeAlD
Epirubicin—YWHAG—head—epilepsy syndrome	0.00126	0.0173	CbGeAlD
Epirubicin—DHCR7—central nervous system—epilepsy syndrome	0.00126	0.0172	CbGeAlD
Epirubicin—DHCR7—cerebellum—epilepsy syndrome	0.00123	0.0168	CbGeAlD
Epirubicin—TOP2A—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.00123	0.222	CbGdCrCtD
Epirubicin—YWHAG—nervous system—epilepsy syndrome	0.0012	0.0164	CbGeAlD
Epirubicin—AURKA—brain—epilepsy syndrome	0.00119	0.0163	CbGeAlD
Epirubicin—PLA2G4A—medulla oblongata—epilepsy syndrome	0.00119	0.0162	CbGeAlD
Epirubicin—YWHAG—central nervous system—epilepsy syndrome	0.00115	0.0157	CbGeAlD
Epirubicin—YWHAG—cerebellum—epilepsy syndrome	0.00113	0.0154	CbGeAlD
Epirubicin—PLA2G4A—midbrain—epilepsy syndrome	0.00109	0.0148	CbGeAlD
Epirubicin—PLA2G4A—spinal cord—epilepsy syndrome	0.00106	0.0145	CbGeAlD
Epirubicin—DHCR7—brain—epilepsy syndrome	0.000998	0.0136	CbGeAlD
Epirubicin—YWHAG—brain—epilepsy syndrome	0.000916	0.0125	CbGeAlD
Epirubicin—PLA2G4A—nervous system—epilepsy syndrome	0.000894	0.0122	CbGeAlD
Epirubicin—ABCC1—telencephalon—epilepsy syndrome	0.000866	0.0118	CbGeAlD
Epirubicin—PLA2G4A—central nervous system—epilepsy syndrome	0.000861	0.0117	CbGeAlD
Epirubicin—Doxorubicin—NOS2—epilepsy syndrome	0.000764	0.136	CrCbGaD
Epirubicin—PLA2G4A—brain—epilepsy syndrome	0.000683	0.00933	CbGeAlD
Epirubicin—Daunorubicin—ABCC2—epilepsy syndrome	0.000624	0.111	CrCbGaD
Epirubicin—Idarubicin—CYP2D6—epilepsy syndrome	0.0006	0.107	CrCbGaD
Epirubicin—Daunorubicin—ABCG2—epilepsy syndrome	0.000552	0.0981	CrCbGaD
Epirubicin—Doxorubicin—ABCC2—epilepsy syndrome	0.000507	0.0901	CrCbGaD
Epirubicin—ABCC1—cerebellum—epilepsy syndrome	0.000481	0.00657	CbGeAlD
Epirubicin—Doxorubicin—ABCG2—epilepsy syndrome	0.000448	0.0796	CrCbGaD
Epirubicin—AURKA—Bortezomib—Lacosamide—epilepsy syndrome	0.000424	0.0767	CbGdCrCtD
Epirubicin—ABCC1—brain—epilepsy syndrome	0.000391	0.00534	CbGeAlD
Epirubicin—AURKA—Niclosamide—Clonazepam—epilepsy syndrome	0.000294	0.0532	CbGdCrCtD
Epirubicin—Doxorubicin—CYP2D6—epilepsy syndrome	0.000261	0.0464	CrCbGaD
Epirubicin—Daunorubicin—ABCB1—epilepsy syndrome	0.00023	0.0408	CrCbGaD
Epirubicin—Doxorubicin—ABCB1—epilepsy syndrome	0.000186	0.0331	CrCbGaD
Epirubicin—TOP2A—Bortezomib—Lacosamide—epilepsy syndrome	0.000162	0.0293	CbGdCrCtD
Epirubicin—TOP2A—Niclosamide—Clonazepam—epilepsy syndrome	0.000112	0.0203	CbGdCrCtD
Epirubicin—TOP2A—Chlorpromazine—Clobazam—epilepsy syndrome	9.62e-05	0.0174	CbGdCrCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.67e-05	9.1e-05	CcSEcCtD
Epirubicin—Hypotension—Valproic Acid—epilepsy syndrome	3.66e-05	9.07e-05	CcSEcCtD
Epirubicin—Asthenia—Carbamazepine—epilepsy syndrome	3.66e-05	9.07e-05	CcSEcCtD
Epirubicin—Agitation—Gabapentin—epilepsy syndrome	3.66e-05	9.07e-05	CcSEcCtD
Epirubicin—Diarrhoea—Phenytoin—epilepsy syndrome	3.66e-05	9.06e-05	CcSEcCtD
Epirubicin—Discomfort—Pregabalin—epilepsy syndrome	3.65e-05	9.05e-05	CcSEcCtD
Epirubicin—Nausea—Fosphenytoin—epilepsy syndrome	3.65e-05	9.04e-05	CcSEcCtD
Epirubicin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.64e-05	9.02e-05	CcSEcCtD
Epirubicin—Erythema multiforme—Topiramate—epilepsy syndrome	3.64e-05	9.01e-05	CcSEcCtD
Epirubicin—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.64e-05	9e-05	CcSEcCtD
Epirubicin—Vomiting—Felbamate—epilepsy syndrome	3.63e-05	8.99e-05	CcSEcCtD
Epirubicin—Dry mouth—Pregabalin—epilepsy syndrome	3.62e-05	8.96e-05	CcSEcCtD
Epirubicin—Pruritus—Carbamazepine—epilepsy syndrome	3.61e-05	8.95e-05	CcSEcCtD
Epirubicin—Rash—Felbamate—epilepsy syndrome	3.6e-05	8.91e-05	CcSEcCtD
Epirubicin—Eye disorder—Topiramate—epilepsy syndrome	3.6e-05	8.91e-05	CcSEcCtD
Epirubicin—Dermatitis—Felbamate—epilepsy syndrome	3.6e-05	8.91e-05	CcSEcCtD
Epirubicin—Malaise—Gabapentin—epilepsy syndrome	3.59e-05	8.9e-05	CcSEcCtD
Epirubicin—Tinnitus—Topiramate—epilepsy syndrome	3.59e-05	8.89e-05	CcSEcCtD
Epirubicin—Vertigo—Gabapentin—epilepsy syndrome	3.58e-05	8.86e-05	CcSEcCtD
Epirubicin—Headache—Felbamate—epilepsy syndrome	3.58e-05	8.86e-05	CcSEcCtD
Epirubicin—Confusional state—Pregabalin—epilepsy syndrome	3.57e-05	8.85e-05	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.57e-05	8.85e-05	CcSEcCtD
Epirubicin—Cardiac disorder—Topiramate—epilepsy syndrome	3.57e-05	8.85e-05	CcSEcCtD
Epirubicin—Flushing—Topiramate—epilepsy syndrome	3.57e-05	8.85e-05	CcSEcCtD
Epirubicin—Syncope—Gabapentin—epilepsy syndrome	3.57e-05	8.85e-05	CcSEcCtD
Epirubicin—Leukopenia—Gabapentin—epilepsy syndrome	3.57e-05	8.83e-05	CcSEcCtD
Epirubicin—Dizziness—Clonazepam—epilepsy syndrome	3.56e-05	8.82e-05	CcSEcCtD
Epirubicin—Nausea—Vigabatrin—epilepsy syndrome	3.56e-05	8.81e-05	CcSEcCtD
Epirubicin—Vomiting—Zonisamide—epilepsy syndrome	3.55e-05	8.8e-05	CcSEcCtD
Epirubicin—Insomnia—Valproic Acid—epilepsy syndrome	3.55e-05	8.78e-05	CcSEcCtD
Epirubicin—Oedema—Pregabalin—epilepsy syndrome	3.55e-05	8.78e-05	CcSEcCtD
Epirubicin—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.55e-05	8.78e-05	CcSEcCtD
Epirubicin—Asthenia—Lamotrigine—epilepsy syndrome	3.54e-05	8.77e-05	CcSEcCtD
Epirubicin—Dizziness—Phenytoin—epilepsy syndrome	3.54e-05	8.76e-05	CcSEcCtD
Epirubicin—Rash—Zonisamide—epilepsy syndrome	3.52e-05	8.73e-05	CcSEcCtD
Epirubicin—Infection—Pregabalin—epilepsy syndrome	3.52e-05	8.72e-05	CcSEcCtD
Epirubicin—Paraesthesia—Valproic Acid—epilepsy syndrome	3.52e-05	8.72e-05	CcSEcCtD
Epirubicin—Palpitations—Gabapentin—epilepsy syndrome	3.52e-05	8.72e-05	CcSEcCtD
Epirubicin—Dermatitis—Zonisamide—epilepsy syndrome	3.52e-05	8.72e-05	CcSEcCtD
Epirubicin—Dizziness—Oxcarbazepine—epilepsy syndrome	3.52e-05	8.71e-05	CcSEcCtD
Epirubicin—Nausea—Diazepam—epilepsy syndrome	3.5e-05	8.68e-05	CcSEcCtD
Epirubicin—Loss of consciousness—Gabapentin—epilepsy syndrome	3.5e-05	8.67e-05	CcSEcCtD
Epirubicin—Headache—Zonisamide—epilepsy syndrome	3.5e-05	8.67e-05	CcSEcCtD
Epirubicin—Dyspnoea—Valproic Acid—epilepsy syndrome	3.5e-05	8.66e-05	CcSEcCtD
Epirubicin—Diarrhoea—Carbamazepine—epilepsy syndrome	3.49e-05	8.65e-05	CcSEcCtD
Epirubicin—Angiopathy—Topiramate—epilepsy syndrome	3.49e-05	8.65e-05	CcSEcCtD
Epirubicin—Pruritus—Lamotrigine—epilepsy syndrome	3.49e-05	8.65e-05	CcSEcCtD
Epirubicin—Shock—Pregabalin—epilepsy syndrome	3.49e-05	8.64e-05	CcSEcCtD
Epirubicin—Somnolence—Valproic Acid—epilepsy syndrome	3.49e-05	8.63e-05	CcSEcCtD
Epirubicin—Immune system disorder—Topiramate—epilepsy syndrome	3.48e-05	8.61e-05	CcSEcCtD
Epirubicin—Nervous system disorder—Pregabalin—epilepsy syndrome	3.48e-05	8.61e-05	CcSEcCtD
Epirubicin—Cough—Gabapentin—epilepsy syndrome	3.48e-05	8.61e-05	CcSEcCtD
Epirubicin—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.47e-05	8.6e-05	CcSEcCtD
Epirubicin—Mediastinal disorder—Topiramate—epilepsy syndrome	3.47e-05	8.59e-05	CcSEcCtD
Epirubicin—Tachycardia—Pregabalin—epilepsy syndrome	3.46e-05	8.57e-05	CcSEcCtD
Epirubicin—Chills—Topiramate—epilepsy syndrome	3.45e-05	8.55e-05	CcSEcCtD
Epirubicin—Dyspepsia—Valproic Acid—epilepsy syndrome	3.45e-05	8.55e-05	CcSEcCtD
Epirubicin—Convulsion—Gabapentin—epilepsy syndrome	3.45e-05	8.55e-05	CcSEcCtD
Epirubicin—Skin disorder—Pregabalin—epilepsy syndrome	3.44e-05	8.53e-05	CcSEcCtD
Epirubicin—Hypertension—Gabapentin—epilepsy syndrome	3.44e-05	8.52e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.43e-05	8.49e-05	CcSEcCtD
Epirubicin—Vomiting—Clonazepam—epilepsy syndrome	3.42e-05	8.48e-05	CcSEcCtD
Epirubicin—Decreased appetite—Valproic Acid—epilepsy syndrome	3.41e-05	8.44e-05	CcSEcCtD
Epirubicin—Alopecia—Topiramate—epilepsy syndrome	3.4e-05	8.42e-05	CcSEcCtD
Epirubicin—Vomiting—Phenytoin—epilepsy syndrome	3.4e-05	8.42e-05	CcSEcCtD
Epirubicin—Rash—Clonazepam—epilepsy syndrome	3.4e-05	8.41e-05	CcSEcCtD
Epirubicin—Dermatitis—Clonazepam—epilepsy syndrome	3.39e-05	8.4e-05	CcSEcCtD
Epirubicin—Chest pain—Gabapentin—epilepsy syndrome	3.39e-05	8.4e-05	CcSEcCtD
Epirubicin—Myalgia—Gabapentin—epilepsy syndrome	3.39e-05	8.4e-05	CcSEcCtD
Epirubicin—Arthralgia—Gabapentin—epilepsy syndrome	3.39e-05	8.4e-05	CcSEcCtD
Epirubicin—Nausea—Felbamate—epilepsy syndrome	3.39e-05	8.4e-05	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.39e-05	8.38e-05	CcSEcCtD
Epirubicin—Vomiting—Oxcarbazepine—epilepsy syndrome	3.38e-05	8.38e-05	CcSEcCtD
Epirubicin—Fatigue—Valproic Acid—epilepsy syndrome	3.38e-05	8.37e-05	CcSEcCtD
Epirubicin—Anxiety—Gabapentin—epilepsy syndrome	3.38e-05	8.37e-05	CcSEcCtD
Epirubicin—Anorexia—Pregabalin—epilepsy syndrome	3.38e-05	8.37e-05	CcSEcCtD
Epirubicin—Dizziness—Carbamazepine—epilepsy syndrome	3.38e-05	8.36e-05	CcSEcCtD
Epirubicin—Diarrhoea—Lamotrigine—epilepsy syndrome	3.38e-05	8.36e-05	CcSEcCtD
Epirubicin—Headache—Clonazepam—epilepsy syndrome	3.37e-05	8.35e-05	CcSEcCtD
Epirubicin—Rash—Phenytoin—epilepsy syndrome	3.37e-05	8.35e-05	CcSEcCtD
Epirubicin—Mental disorder—Topiramate—epilepsy syndrome	3.37e-05	8.35e-05	CcSEcCtD
Epirubicin—Dermatitis—Phenytoin—epilepsy syndrome	3.37e-05	8.34e-05	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.37e-05	8.34e-05	CcSEcCtD
Epirubicin—Rash—Oxcarbazepine—epilepsy syndrome	3.36e-05	8.31e-05	CcSEcCtD
Epirubicin—Constipation—Valproic Acid—epilepsy syndrome	3.35e-05	8.3e-05	CcSEcCtD
Epirubicin—Pain—Valproic Acid—epilepsy syndrome	3.35e-05	8.3e-05	CcSEcCtD
Epirubicin—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.35e-05	8.3e-05	CcSEcCtD
Epirubicin—Headache—Phenytoin—epilepsy syndrome	3.35e-05	8.3e-05	CcSEcCtD
Epirubicin—Erythema—Topiramate—epilepsy syndrome	3.35e-05	8.3e-05	CcSEcCtD
Epirubicin—Malnutrition—Topiramate—epilepsy syndrome	3.35e-05	8.3e-05	CcSEcCtD
Epirubicin—Discomfort—Gabapentin—epilepsy syndrome	3.35e-05	8.3e-05	CcSEcCtD
Epirubicin—Headache—Oxcarbazepine—epilepsy syndrome	3.33e-05	8.26e-05	CcSEcCtD
Epirubicin—Nausea—Zonisamide—epilepsy syndrome	3.32e-05	8.22e-05	CcSEcCtD
Epirubicin—Dry mouth—Gabapentin—epilepsy syndrome	3.32e-05	8.21e-05	CcSEcCtD
Epirubicin—Hypotension—Pregabalin—epilepsy syndrome	3.31e-05	8.2e-05	CcSEcCtD
Epirubicin—Flatulence—Topiramate—epilepsy syndrome	3.3e-05	8.18e-05	CcSEcCtD
Epirubicin—Tension—Topiramate—epilepsy syndrome	3.29e-05	8.14e-05	CcSEcCtD
Epirubicin—Dysgeusia—Topiramate—epilepsy syndrome	3.28e-05	8.13e-05	CcSEcCtD
Epirubicin—Confusional state—Gabapentin—epilepsy syndrome	3.28e-05	8.12e-05	CcSEcCtD
Epirubicin—Dizziness—Lamotrigine—epilepsy syndrome	3.26e-05	8.08e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR3—epilepsy syndrome	3.26e-05	0.000243	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.26e-05	0.000243	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	3.26e-05	0.000242	CbGpPWpGaD
Epirubicin—Nervousness—Topiramate—epilepsy syndrome	3.25e-05	8.06e-05	CcSEcCtD
Epirubicin—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.25e-05	8.05e-05	CcSEcCtD
Epirubicin—Oedema—Gabapentin—epilepsy syndrome	3.25e-05	8.05e-05	CcSEcCtD
Epirubicin—Vomiting—Carbamazepine—epilepsy syndrome	3.25e-05	8.04e-05	CcSEcCtD
Epirubicin—Back pain—Topiramate—epilepsy syndrome	3.24e-05	8.03e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—YWHAZ—epilepsy syndrome	3.24e-05	0.000241	CbGpPWpGaD
Epirubicin—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.23e-05	8e-05	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.23e-05	8e-05	CcSEcCtD
Epirubicin—Infection—Gabapentin—epilepsy syndrome	3.23e-05	8e-05	CcSEcCtD
Epirubicin—Muscle spasms—Topiramate—epilepsy syndrome	3.22e-05	7.98e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—TXNRD1—epilepsy syndrome	3.22e-05	0.00024	CbGpPWpGaD
Epirubicin—Rash—Carbamazepine—epilepsy syndrome	3.22e-05	7.97e-05	CcSEcCtD
Epirubicin—Dermatitis—Carbamazepine—epilepsy syndrome	3.22e-05	7.97e-05	CcSEcCtD
Epirubicin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.21e-05	7.94e-05	CcSEcCtD
Epirubicin—Insomnia—Pregabalin—epilepsy syndrome	3.21e-05	7.94e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—STXBP1—epilepsy syndrome	3.21e-05	0.000239	CbGpPWpGaD
Epirubicin—Nausea—Clonazepam—epilepsy syndrome	3.2e-05	7.92e-05	CcSEcCtD
Epirubicin—Headache—Carbamazepine—epilepsy syndrome	3.2e-05	7.92e-05	CcSEcCtD
Epirubicin—Shock—Gabapentin—epilepsy syndrome	3.2e-05	7.92e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—AQP1—epilepsy syndrome	3.19e-05	0.000237	CbGpPWpGaD
Epirubicin—Nervous system disorder—Gabapentin—epilepsy syndrome	3.19e-05	7.9e-05	CcSEcCtD
Epirubicin—Paraesthesia—Pregabalin—epilepsy syndrome	3.18e-05	7.88e-05	CcSEcCtD
Epirubicin—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.18e-05	7.88e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—NPY—epilepsy syndrome	3.18e-05	0.000237	CbGpPWpGaD
Epirubicin—Nausea—Phenytoin—epilepsy syndrome	3.18e-05	7.87e-05	CcSEcCtD
Epirubicin—Tachycardia—Gabapentin—epilepsy syndrome	3.17e-05	7.86e-05	CcSEcCtD
Epirubicin—Dyspnoea—Pregabalin—epilepsy syndrome	3.16e-05	7.83e-05	CcSEcCtD
Epirubicin—Nausea—Oxcarbazepine—epilepsy syndrome	3.16e-05	7.83e-05	CcSEcCtD
Epirubicin—Vision blurred—Topiramate—epilepsy syndrome	3.16e-05	7.82e-05	CcSEcCtD
Epirubicin—Skin disorder—Gabapentin—epilepsy syndrome	3.16e-05	7.82e-05	CcSEcCtD
Epirubicin—Somnolence—Pregabalin—epilepsy syndrome	3.15e-05	7.81e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.14e-05	7.78e-05	CcSEcCtD
Epirubicin—Vomiting—Lamotrigine—epilepsy syndrome	3.14e-05	7.77e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—AQP1—epilepsy syndrome	3.13e-05	0.000233	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NT5E—epilepsy syndrome	3.12e-05	0.000233	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALAD—epilepsy syndrome	3.12e-05	0.000233	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SSTR3—epilepsy syndrome	3.12e-05	0.000232	CbGpPWpGaD
Epirubicin—Urticaria—Valproic Acid—epilepsy syndrome	3.12e-05	7.71e-05	CcSEcCtD
Epirubicin—Rash—Lamotrigine—epilepsy syndrome	3.11e-05	7.71e-05	CcSEcCtD
Epirubicin—Ill-defined disorder—Topiramate—epilepsy syndrome	3.11e-05	7.7e-05	CcSEcCtD
Epirubicin—Dermatitis—Lamotrigine—epilepsy syndrome	3.11e-05	7.7e-05	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.11e-05	0.000231	CbGpPWpGaD
Epirubicin—Abdominal pain—Valproic Acid—epilepsy syndrome	3.1e-05	7.68e-05	CcSEcCtD
Epirubicin—Body temperature increased—Valproic Acid—epilepsy syndrome	3.1e-05	7.68e-05	CcSEcCtD
Epirubicin—Anorexia—Gabapentin—epilepsy syndrome	3.1e-05	7.67e-05	CcSEcCtD
Epirubicin—Anaemia—Topiramate—epilepsy syndrome	3.1e-05	7.67e-05	CcSEcCtD
Epirubicin—Headache—Lamotrigine—epilepsy syndrome	3.09e-05	7.66e-05	CcSEcCtD
Epirubicin—Decreased appetite—Pregabalin—epilepsy syndrome	3.08e-05	7.63e-05	CcSEcCtD
Epirubicin—Agitation—Topiramate—epilepsy syndrome	3.08e-05	7.63e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—OXT—epilepsy syndrome	3.07e-05	0.000228	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CRH—epilepsy syndrome	3.07e-05	0.000228	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL2—epilepsy syndrome	3.07e-05	0.000228	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL3—epilepsy syndrome	3.07e-05	0.000228	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.06e-05	7.58e-05	CcSEcCtD
Epirubicin—Fatigue—Pregabalin—epilepsy syndrome	3.06e-05	7.57e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.05e-05	0.000227	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	3.05e-05	0.000227	CbGpPWpGaD
Epirubicin—Hypotension—Gabapentin—epilepsy syndrome	3.04e-05	7.52e-05	CcSEcCtD
Epirubicin—Nausea—Carbamazepine—epilepsy syndrome	3.03e-05	7.51e-05	CcSEcCtD
Epirubicin—Constipation—Pregabalin—epilepsy syndrome	3.03e-05	7.51e-05	CcSEcCtD
Epirubicin—Pain—Pregabalin—epilepsy syndrome	3.03e-05	7.51e-05	CcSEcCtD
Epirubicin—Malaise—Topiramate—epilepsy syndrome	3.02e-05	7.48e-05	CcSEcCtD
Epirubicin—Vertigo—Topiramate—epilepsy syndrome	3.01e-05	7.46e-05	CcSEcCtD
Epirubicin—Syncope—Topiramate—epilepsy syndrome	3.01e-05	7.44e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3e-05	0.000224	CbGpPWpGaD
Epirubicin—Leukopenia—Topiramate—epilepsy syndrome	3e-05	7.43e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—NPY2R—epilepsy syndrome	2.99e-05	0.000223	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ARHGEF9—epilepsy syndrome	2.99e-05	0.000223	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SSTR1—epilepsy syndrome	2.99e-05	0.000223	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR9—epilepsy syndrome	2.99e-05	0.000223	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR8—epilepsy syndrome	2.99e-05	0.000223	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALDH7A1—epilepsy syndrome	2.98e-05	0.000222	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CACNA1A—epilepsy syndrome	2.98e-05	0.000222	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—ATM—epilepsy syndrome	2.97e-05	0.000221	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	2.97e-05	0.000221	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.96e-05	7.33e-05	CcSEcCtD
Epirubicin—Palpitations—Topiramate—epilepsy syndrome	2.96e-05	7.33e-05	CcSEcCtD
Epirubicin—Loss of consciousness—Topiramate—epilepsy syndrome	2.95e-05	7.29e-05	CcSEcCtD
Epirubicin—Insomnia—Gabapentin—epilepsy syndrome	2.94e-05	7.28e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—GRM3—epilepsy syndrome	2.93e-05	0.000218	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GRM4—epilepsy syndrome	2.93e-05	0.000218	CbGpPWpGaD
Epirubicin—Nausea—Lamotrigine—epilepsy syndrome	2.93e-05	7.26e-05	CcSEcCtD
Epirubicin—Cough—Topiramate—epilepsy syndrome	2.92e-05	7.24e-05	CcSEcCtD
Epirubicin—Feeling abnormal—Pregabalin—epilepsy syndrome	2.92e-05	7.23e-05	CcSEcCtD
Epirubicin—Paraesthesia—Gabapentin—epilepsy syndrome	2.92e-05	7.23e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—ST3GAL3—epilepsy syndrome	2.92e-05	0.000217	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—POMC—epilepsy syndrome	2.92e-05	0.000217	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—PRKCB—epilepsy syndrome	2.91e-05	0.000217	CbGpPWpGaD
Epirubicin—Convulsion—Topiramate—epilepsy syndrome	2.9e-05	7.19e-05	CcSEcCtD
Epirubicin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.9e-05	7.18e-05	CcSEcCtD
Epirubicin—Dyspnoea—Gabapentin—epilepsy syndrome	2.9e-05	7.18e-05	CcSEcCtD
Epirubicin—Hypertension—Topiramate—epilepsy syndrome	2.89e-05	7.17e-05	CcSEcCtD
Epirubicin—Somnolence—Gabapentin—epilepsy syndrome	2.89e-05	7.16e-05	CcSEcCtD
Epirubicin—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.89e-05	7.15e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—KCNJ11—epilepsy syndrome	2.88e-05	0.000215	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CHRM3—epilepsy syndrome	2.88e-05	0.000215	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—DUSP4—epilepsy syndrome	2.88e-05	0.000214	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SSTR2—epilepsy syndrome	2.88e-05	0.000214	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PLAU—epilepsy syndrome	2.87e-05	0.000214	CbGpPWpGaD
Epirubicin—Dyspepsia—Gabapentin—epilepsy syndrome	2.86e-05	7.09e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—ADSL—epilepsy syndrome	2.86e-05	0.000213	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.86e-05	0.000213	CbGpPWpGaD
Epirubicin—Myalgia—Topiramate—epilepsy syndrome	2.85e-05	7.07e-05	CcSEcCtD
Epirubicin—Chest pain—Topiramate—epilepsy syndrome	2.85e-05	7.07e-05	CcSEcCtD
Epirubicin—Arthralgia—Topiramate—epilepsy syndrome	2.85e-05	7.07e-05	CcSEcCtD
Epirubicin—Anxiety—Topiramate—epilepsy syndrome	2.84e-05	7.04e-05	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.83e-05	7.02e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—KCNJ11—epilepsy syndrome	2.83e-05	0.00021	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CHRM3—epilepsy syndrome	2.83e-05	0.00021	CbGpPWpGaD
Epirubicin—Decreased appetite—Gabapentin—epilepsy syndrome	2.83e-05	7e-05	CcSEcCtD
Epirubicin—Discomfort—Topiramate—epilepsy syndrome	2.82e-05	6.98e-05	CcSEcCtD
Epirubicin—Urticaria—Pregabalin—epilepsy syndrome	2.82e-05	6.97e-05	CcSEcCtD
Epirubicin—Asthenia—Valproic Acid—epilepsy syndrome	2.81e-05	6.97e-05	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.81e-05	6.95e-05	CcSEcCtD
Epirubicin—Fatigue—Gabapentin—epilepsy syndrome	2.8e-05	6.94e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—GLUL—epilepsy syndrome	2.8e-05	0.000209	CbGpPWpGaD
Epirubicin—Body temperature increased—Pregabalin—epilepsy syndrome	2.8e-05	6.94e-05	CcSEcCtD
Epirubicin—Abdominal pain—Pregabalin—epilepsy syndrome	2.8e-05	6.94e-05	CcSEcCtD
Epirubicin—Dry mouth—Topiramate—epilepsy syndrome	2.79e-05	6.91e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—GRM8—epilepsy syndrome	2.78e-05	0.000207	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PGF—epilepsy syndrome	2.78e-05	0.000207	CbGpPWpGaD
Epirubicin—Pain—Gabapentin—epilepsy syndrome	2.78e-05	6.88e-05	CcSEcCtD
Epirubicin—Constipation—Gabapentin—epilepsy syndrome	2.78e-05	6.88e-05	CcSEcCtD
Epirubicin—Pruritus—Valproic Acid—epilepsy syndrome	2.77e-05	6.87e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR2—epilepsy syndrome	2.77e-05	0.000206	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—SST—epilepsy syndrome	2.77e-05	0.000206	CbGpPWpGaD
Epirubicin—Confusional state—Topiramate—epilepsy syndrome	2.76e-05	6.83e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—CACNA1D—epilepsy syndrome	2.75e-05	0.000205	CbGpPWpGaD
Epirubicin—Oedema—Topiramate—epilepsy syndrome	2.74e-05	6.77e-05	CcSEcCtD
Epirubicin—Infection—Topiramate—epilepsy syndrome	2.72e-05	6.73e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.71e-05	0.000202	CbGpPWpGaD
Epirubicin—Shock—Topiramate—epilepsy syndrome	2.69e-05	6.66e-05	CcSEcCtD
Epirubicin—Diarrhoea—Valproic Acid—epilepsy syndrome	2.68e-05	6.64e-05	CcSEcCtD
Epirubicin—Nervous system disorder—Topiramate—epilepsy syndrome	2.68e-05	6.64e-05	CcSEcCtD
Epirubicin—Feeling abnormal—Gabapentin—epilepsy syndrome	2.68e-05	6.63e-05	CcSEcCtD
Epirubicin—Thrombocytopenia—Topiramate—epilepsy syndrome	2.68e-05	6.63e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—PRKCB—epilepsy syndrome	2.67e-05	0.000199	CbGpPWpGaD
Epirubicin—Tachycardia—Topiramate—epilepsy syndrome	2.67e-05	6.61e-05	CcSEcCtD
Epirubicin—DHCR7—Metabolism—ALB—epilepsy syndrome	2.66e-05	0.000198	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.66e-05	6.58e-05	CcSEcCtD
Epirubicin—Skin disorder—Topiramate—epilepsy syndrome	2.66e-05	6.58e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—GNAO1—epilepsy syndrome	2.65e-05	0.000197	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—OPRD1—epilepsy syndrome	2.65e-05	0.000197	CbGpPWpGaD
Epirubicin—Hyperhidrosis—Topiramate—epilepsy syndrome	2.64e-05	6.55e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—NOS2—epilepsy syndrome	2.64e-05	0.000197	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.63e-05	0.000196	CbGpPWpGaD
Epirubicin—Hypersensitivity—Pregabalin—epilepsy syndrome	2.61e-05	6.47e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.61e-05	0.000194	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL12—epilepsy syndrome	2.61e-05	0.000194	CbGpPWpGaD
Epirubicin—Anorexia—Topiramate—epilepsy syndrome	2.61e-05	6.46e-05	CcSEcCtD
Epirubicin—Dizziness—Valproic Acid—epilepsy syndrome	2.59e-05	6.42e-05	CcSEcCtD
Epirubicin—Urticaria—Gabapentin—epilepsy syndrome	2.58e-05	6.4e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.58e-05	0.000192	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TXNRD1—epilepsy syndrome	2.57e-05	0.000192	CbGpPWpGaD
Epirubicin—Body temperature increased—Gabapentin—epilepsy syndrome	2.57e-05	6.36e-05	CcSEcCtD
Epirubicin—Abdominal pain—Gabapentin—epilepsy syndrome	2.57e-05	6.36e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CNR1—epilepsy syndrome	2.56e-05	0.000191	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.56e-05	0.00019	CbGpPWpGaD
Epirubicin—Hypotension—Topiramate—epilepsy syndrome	2.56e-05	6.33e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—PLCB1—epilepsy syndrome	2.55e-05	0.00019	CbGpPWpGaD
Epirubicin—Asthenia—Pregabalin—epilepsy syndrome	2.54e-05	6.3e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—PDYN—epilepsy syndrome	2.54e-05	0.000189	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GRM1—epilepsy syndrome	2.54e-05	0.000189	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR7—epilepsy syndrome	2.54e-05	0.000189	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CHRM1—epilepsy syndrome	2.54e-05	0.000189	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EIF2AK2—epilepsy syndrome	2.54e-05	0.000189	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.53e-05	0.000189	CbGpPWpGaD
Epirubicin—Pruritus—Pregabalin—epilepsy syndrome	2.51e-05	6.21e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—AQP1—epilepsy syndrome	2.5e-05	0.000186	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HTR7—epilepsy syndrome	2.5e-05	0.000186	CbGpPWpGaD
Epirubicin—Vomiting—Valproic Acid—epilepsy syndrome	2.49e-05	6.17e-05	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.49e-05	6.17e-05	CcSEcCtD
Epirubicin—Insomnia—Topiramate—epilepsy syndrome	2.47e-05	6.13e-05	CcSEcCtD
Epirubicin—Rash—Valproic Acid—epilepsy syndrome	2.47e-05	6.12e-05	CcSEcCtD
Epirubicin—Dermatitis—Valproic Acid—epilepsy syndrome	2.47e-05	6.12e-05	CcSEcCtD
Epirubicin—Headache—Valproic Acid—epilepsy syndrome	2.46e-05	6.08e-05	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.46e-05	0.000183	CbGpPWpGaD
Epirubicin—Paraesthesia—Topiramate—epilepsy syndrome	2.46e-05	6.08e-05	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.45e-05	0.000183	CbGpPWpGaD
Epirubicin—Dyspnoea—Topiramate—epilepsy syndrome	2.44e-05	6.04e-05	CcSEcCtD
Epirubicin—Somnolence—Topiramate—epilepsy syndrome	2.43e-05	6.02e-05	CcSEcCtD
Epirubicin—Diarrhoea—Pregabalin—epilepsy syndrome	2.43e-05	6.01e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—HBEGF—epilepsy syndrome	2.42e-05	0.00018	CbGpPWpGaD
Epirubicin—Dyspepsia—Topiramate—epilepsy syndrome	2.41e-05	5.96e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.4e-05	0.000179	CbGpPWpGaD
Epirubicin—Hypersensitivity—Gabapentin—epilepsy syndrome	2.4e-05	5.93e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—GAL—epilepsy syndrome	2.39e-05	0.000178	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GFAP—epilepsy syndrome	2.39e-05	0.000178	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT3—epilepsy syndrome	2.38e-05	0.000177	CbGpPWpGaD
Epirubicin—Decreased appetite—Topiramate—epilepsy syndrome	2.38e-05	5.89e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CASP2—epilepsy syndrome	2.36e-05	0.000176	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CHRM3—epilepsy syndrome	2.36e-05	0.000176	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GRM5—epilepsy syndrome	2.36e-05	0.000176	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.36e-05	5.85e-05	CcSEcCtD
Epirubicin—Fatigue—Topiramate—epilepsy syndrome	2.36e-05	5.84e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ABCG2—epilepsy syndrome	2.35e-05	0.000175	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PPIA—epilepsy syndrome	2.35e-05	0.000175	CbGpPWpGaD
Epirubicin—Dizziness—Pregabalin—epilepsy syndrome	2.34e-05	5.81e-05	CcSEcCtD
Epirubicin—Constipation—Topiramate—epilepsy syndrome	2.34e-05	5.79e-05	CcSEcCtD
Epirubicin—Pain—Topiramate—epilepsy syndrome	2.34e-05	5.79e-05	CcSEcCtD
Epirubicin—Asthenia—Gabapentin—epilepsy syndrome	2.33e-05	5.78e-05	CcSEcCtD
Epirubicin—Nausea—Valproic Acid—epilepsy syndrome	2.33e-05	5.77e-05	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTGS2—epilepsy syndrome	2.33e-05	0.000173	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ABCG2—epilepsy syndrome	2.31e-05	0.000172	CbGpPWpGaD
Epirubicin—Pruritus—Gabapentin—epilepsy syndrome	2.3e-05	5.7e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—CYP2C19—epilepsy syndrome	2.29e-05	0.00017	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP11A1—epilepsy syndrome	2.28e-05	0.000169	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CX3CR1—epilepsy syndrome	2.27e-05	0.000169	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—KCNJ11—epilepsy syndrome	2.26e-05	0.000168	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CHRM3—epilepsy syndrome	2.26e-05	0.000168	CbGpPWpGaD
Epirubicin—Vomiting—Pregabalin—epilepsy syndrome	2.25e-05	5.58e-05	CcSEcCtD
Epirubicin—Feeling abnormal—Topiramate—epilepsy syndrome	2.25e-05	5.58e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—CYP2C19—epilepsy syndrome	2.25e-05	0.000167	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.24e-05	5.54e-05	CcSEcCtD
Epirubicin—Rash—Pregabalin—epilepsy syndrome	2.24e-05	5.54e-05	CcSEcCtD
Epirubicin—Dermatitis—Pregabalin—epilepsy syndrome	2.23e-05	5.53e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—CYP11A1—epilepsy syndrome	2.23e-05	0.000166	CbGpPWpGaD
Epirubicin—Diarrhoea—Gabapentin—epilepsy syndrome	2.22e-05	5.51e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CHRM2—epilepsy syndrome	2.22e-05	0.000165	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BDKRB1—epilepsy syndrome	2.22e-05	0.000165	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CX3CL1—epilepsy syndrome	2.22e-05	0.000165	CbGpPWpGaD
Epirubicin—Headache—Pregabalin—epilepsy syndrome	2.22e-05	5.5e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—ALB—epilepsy syndrome	2.22e-05	0.000165	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.22e-05	0.000165	CbGpPWpGaD
Epirubicin—Urticaria—Topiramate—epilepsy syndrome	2.17e-05	5.38e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CDC42—epilepsy syndrome	2.17e-05	0.000162	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GABBR1—epilepsy syndrome	2.16e-05	0.000161	CbGpPWpGaD
Epirubicin—Abdominal pain—Topiramate—epilepsy syndrome	2.16e-05	5.35e-05	CcSEcCtD
Epirubicin—Body temperature increased—Topiramate—epilepsy syndrome	2.16e-05	5.35e-05	CcSEcCtD
Epirubicin—Dizziness—Gabapentin—epilepsy syndrome	2.15e-05	5.32e-05	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.13e-05	0.000158	CbGpPWpGaD
Epirubicin—Nausea—Pregabalin—epilepsy syndrome	2.11e-05	5.21e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.1e-05	0.000157	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AVP—epilepsy syndrome	2.1e-05	0.000156	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HRH3—epilepsy syndrome	2.07e-05	0.000154	CbGpPWpGaD
Epirubicin—Vomiting—Gabapentin—epilepsy syndrome	2.07e-05	5.12e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.06e-05	0.000153	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP2D6—epilepsy syndrome	2.05e-05	0.000153	CbGpPWpGaD
Epirubicin—Rash—Gabapentin—epilepsy syndrome	2.05e-05	5.08e-05	CcSEcCtD
Epirubicin—Dermatitis—Gabapentin—epilepsy syndrome	2.05e-05	5.07e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—OPRM1—epilepsy syndrome	2.04e-05	0.000152	CbGpPWpGaD
Epirubicin—Headache—Gabapentin—epilepsy syndrome	2.04e-05	5.04e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.02e-05	0.00015	CbGpPWpGaD
Epirubicin—Hypersensitivity—Topiramate—epilepsy syndrome	2.02e-05	4.99e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—CYP2D6—epilepsy syndrome	2.01e-05	0.00015	CbGpPWpGaD
Epirubicin—Asthenia—Topiramate—epilepsy syndrome	1.96e-05	4.86e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ADRA2A—epilepsy syndrome	1.96e-05	0.000146	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—BCHE—epilepsy syndrome	1.95e-05	0.000145	CbGpPWpGaD
Epirubicin—Pruritus—Topiramate—epilepsy syndrome	1.94e-05	4.79e-05	CcSEcCtD
Epirubicin—Nausea—Gabapentin—epilepsy syndrome	1.93e-05	4.78e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CCR3—epilepsy syndrome	1.93e-05	0.000143	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ADRA2A—epilepsy syndrome	1.92e-05	0.000143	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—BCHE—epilepsy syndrome	1.91e-05	0.000142	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.89e-05	0.000141	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NPY—epilepsy syndrome	1.88e-05	0.00014	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.88e-05	0.00014	CbGpPWpGaD
Epirubicin—Diarrhoea—Topiramate—epilepsy syndrome	1.87e-05	4.63e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—SLC2A1—epilepsy syndrome	1.86e-05	0.000138	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCG2—epilepsy syndrome	1.84e-05	0.000137	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PLCB1—epilepsy syndrome	1.84e-05	0.000137	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—TH—epilepsy syndrome	1.83e-05	0.000136	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC2A1—epilepsy syndrome	1.82e-05	0.000136	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—OXT—epilepsy syndrome	1.81e-05	0.000135	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HSPB1—epilepsy syndrome	1.81e-05	0.000135	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL2—epilepsy syndrome	1.81e-05	0.000135	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CRH—epilepsy syndrome	1.81e-05	0.000135	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL3—epilepsy syndrome	1.81e-05	0.000135	CbGpPWpGaD
Epirubicin—Dizziness—Topiramate—epilepsy syndrome	1.81e-05	4.48e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—PLCB1—epilepsy syndrome	1.8e-05	0.000134	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—TH—epilepsy syndrome	1.8e-05	0.000134	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2C19—epilepsy syndrome	1.79e-05	0.000134	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR5—epilepsy syndrome	1.79e-05	0.000133	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP11A1—epilepsy syndrome	1.78e-05	0.000133	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.77e-05	0.000132	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.77e-05	0.000132	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.75e-05	0.00013	CbGpPWpGaD
Epirubicin—Vomiting—Topiramate—epilepsy syndrome	1.74e-05	4.31e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—SLC2A1—epilepsy syndrome	1.74e-05	0.000129	CbGpPWpGaD
Epirubicin—ABCC1—Disease—JUNB—epilepsy syndrome	1.73e-05	0.000128	CbGpPWpGaD
Epirubicin—Rash—Topiramate—epilepsy syndrome	1.72e-05	4.27e-05	CcSEcCtD
Epirubicin—Dermatitis—Topiramate—epilepsy syndrome	1.72e-05	4.27e-05	CcSEcCtD
Epirubicin—Headache—Topiramate—epilepsy syndrome	1.71e-05	4.24e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—NOS1—epilepsy syndrome	1.71e-05	0.000128	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TSC1—epilepsy syndrome	1.68e-05	0.000125	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTK2B—epilepsy syndrome	1.68e-05	0.000125	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AGT—epilepsy syndrome	1.66e-05	0.000124	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NTRK2—epilepsy syndrome	1.64e-05	0.000122	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SST—epilepsy syndrome	1.64e-05	0.000122	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR2—epilepsy syndrome	1.64e-05	0.000122	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HBEGF—epilepsy syndrome	1.63e-05	0.000122	CbGpPWpGaD
Epirubicin—Nausea—Topiramate—epilepsy syndrome	1.62e-05	4.02e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—DUSP6—epilepsy syndrome	1.62e-05	0.000121	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.61e-05	0.00012	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2D6—epilepsy syndrome	1.61e-05	0.00012	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT3—epilepsy syndrome	1.6e-05	0.000119	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRA2A—epilepsy syndrome	1.6e-05	0.000119	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PLAT—epilepsy syndrome	1.6e-05	0.000119	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SRC—epilepsy syndrome	1.57e-05	0.000117	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ADAM10—epilepsy syndrome	1.57e-05	0.000117	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.54e-05	0.000115	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL12—epilepsy syndrome	1.54e-05	0.000115	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.54e-05	0.000114	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.53e-05	0.000114	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ADRA2A—epilepsy syndrome	1.53e-05	0.000114	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—epilepsy syndrome	1.53e-05	0.000114	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMOX1—epilepsy syndrome	1.53e-05	0.000114	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.53e-05	0.000114	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—BCHE—epilepsy syndrome	1.53e-05	0.000114	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JUNB—epilepsy syndrome	1.51e-05	0.000113	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CNR1—epilepsy syndrome	1.51e-05	0.000113	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CAT—epilepsy syndrome	1.51e-05	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PLCB1—epilepsy syndrome	1.51e-05	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMOX1—epilepsy syndrome	1.5e-05	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CAT—epilepsy syndrome	1.48e-05	0.00011	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HTR7—epilepsy syndrome	1.48e-05	0.00011	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ABCB1—epilepsy syndrome	1.47e-05	0.000109	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDC42—epilepsy syndrome	1.46e-05	0.000109	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC2A1—epilepsy syndrome	1.46e-05	0.000108	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PLCB1—epilepsy syndrome	1.44e-05	0.000107	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ABCB1—epilepsy syndrome	1.44e-05	0.000107	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TH—epilepsy syndrome	1.43e-05	0.000107	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HBEGF—epilepsy syndrome	1.43e-05	0.000107	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.41e-05	0.000105	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT3—epilepsy syndrome	1.41e-05	0.000105	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—POMC—epilepsy syndrome	1.4e-05	0.000104	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADAM10—epilepsy syndrome	1.37e-05	0.000102	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL2—epilepsy syndrome	1.37e-05	0.000102	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GPX1—epilepsy syndrome	1.36e-05	0.000102	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HES1—epilepsy syndrome	1.34e-05	9.97e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GPX1—epilepsy syndrome	1.34e-05	9.95e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FYN—epilepsy syndrome	1.3e-05	9.7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—S100B—epilepsy syndrome	1.3e-05	9.67e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—H2AFX—epilepsy syndrome	1.3e-05	9.66e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SOCS3—epilepsy syndrome	1.29e-05	9.57e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDC42—epilepsy syndrome	1.28e-05	9.55e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—YWHAZ—epilepsy syndrome	1.25e-05	9.32e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AVP—epilepsy syndrome	1.24e-05	9.24e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CCR5—epilepsy syndrome	1.2e-05	8.97e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMOX1—epilepsy syndrome	1.2e-05	8.91e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AGT—epilepsy syndrome	1.2e-05	8.9e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CAT—epilepsy syndrome	1.18e-05	8.79e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HES1—epilepsy syndrome	1.17e-05	8.74e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AGT—epilepsy syndrome	1.17e-05	8.73e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOE—epilepsy syndrome	1.17e-05	8.72e-05	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—epilepsy syndrome	1.17e-05	8.7e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCB1—epilepsy syndrome	1.15e-05	8.56e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOE—epilepsy syndrome	1.15e-05	8.55e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FYN—epilepsy syndrome	1.14e-05	8.5e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—H2AFX—epilepsy syndrome	1.14e-05	8.47e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MEF2C—epilepsy syndrome	1.14e-05	8.46e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TSC2—epilepsy syndrome	1.12e-05	8.34e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.1e-05	8.17e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOE—epilepsy syndrome	1.1e-05	8.16e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NGF—epilepsy syndrome	1.09e-05	8.08e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GPX1—epilepsy syndrome	1.07e-05	7.95e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR5—epilepsy syndrome	1.06e-05	7.86e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HTR2A—epilepsy syndrome	1.03e-05	7.69e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6ST—epilepsy syndrome	1.03e-05	7.66e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—epilepsy syndrome	1.02e-05	7.6e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—POMC—epilepsy syndrome	1.01e-05	7.49e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—POMC—epilepsy syndrome	9.87e-06	7.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TSC2—epilepsy syndrome	9.82e-06	7.31e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGT—epilepsy syndrome	9.81e-06	7.3e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT1—epilepsy syndrome	9.76e-06	7.26e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOE—epilepsy syndrome	9.61e-06	7.15e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KDR—epilepsy syndrome	9.41e-06	7.01e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AGT—epilepsy syndrome	9.37e-06	6.97e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOE—epilepsy syndrome	9.18e-06	6.83e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—epilepsy syndrome	9.18e-06	6.83e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCB—epilepsy syndrome	9.06e-06	6.74e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6ST—epilepsy syndrome	9.02e-06	6.72e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—epilepsy syndrome	9e-06	6.7e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGF2—epilepsy syndrome	8.33e-06	6.2e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—POMC—epilepsy syndrome	8.25e-06	6.14e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL2—epilepsy syndrome	8.08e-06	6.01e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	8.03e-06	5.98e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—POMC—epilepsy syndrome	7.89e-06	5.87e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—epilepsy syndrome	7.87e-06	5.86e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTOR—epilepsy syndrome	7.58e-06	5.64e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—epilepsy syndrome	7.51e-06	5.59e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGF2—epilepsy syndrome	7.3e-06	5.43e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—epilepsy syndrome	7.19e-06	5.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RELA—epilepsy syndrome	6.78e-06	5.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MTOR—epilepsy syndrome	6.64e-06	4.95e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—epilepsy syndrome	6.29e-06	4.68e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CASP3—epilepsy syndrome	6.11e-06	4.55e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SRC—epilepsy syndrome	6.07e-06	4.52e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JUN—epilepsy syndrome	5.94e-06	4.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—epilepsy syndrome	5.77e-06	4.3e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—epilepsy syndrome	5.6e-06	4.17e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SRC—epilepsy syndrome	5.32e-06	3.96e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—epilepsy syndrome	5.19e-06	3.86e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—epilepsy syndrome	4.03e-06	3e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—epilepsy syndrome	3.96e-06	2.95e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—epilepsy syndrome	3.78e-06	2.81e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—epilepsy syndrome	3.31e-06	2.46e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—epilepsy syndrome	3.16e-06	2.35e-05	CbGpPWpGaD
